Table 4 Hazard ratios of renal events and non-renal CVD events for the high TG/HDL-C index versus the low TG/HDL-C index.

From: Triglyceride/high density lipoprotein cholesterol index and future cardiovascular events in diabetic patients without known cardiovascular disease

Outcome

Group

Number

of events

Categorical variable

Continuous variable

HR

95% CI

p value

HR

95% CI

p value

Renal events

TG/HDL index < 2.5

31/2652

Reference

  

Reference

  

TG/HDL index ≥ 2.5

60/2013

1.53

0.96–2.46

0.076

1.04

0.97–1.11

0.26

Non-renal

CVD events

TG/HDL index < 2.5

69/2652

Reference

  

Reference

  

TG/HDL index ≥ 2.5

106/2013

1.99

1.45–2.74

 < 0.001

1.09

1.05–1.14

 < 0.001

  1. Multivariate Cox regression analysis of renal events and non-renal CVD events for the high TG/HDL-C index versus the low TG/HDL-C index using Model 4. Model 4 was adjusted for age, sex, statin treatment allocation of the EMPATHY study, body mass index, smoking, hypertension, systolic blood pressure, low-density lipoprotein cholesterol, hemoglobin A1c, estimated glomerular filtration rate, log B-type natriuretic peptide, diabetic neuropathy or nephropathy, and prescribed drugs: Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor, calcium channel blocker, β-blocker, and diuretic. CVD, cardiovascular disease; HDL-C, high density lipoprotein cholesterol; TG, triglyceride.